These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21334390)
1. From kidney development to drug delivery and tissue engineering strategies in renal regenerative medicine. Dankers PY; Boomker JM; Meijer EW; Popa ER; van Luyn MJ J Control Release; 2011 May; 152(1):177-85. PubMed ID: 21334390 [TBL] [Abstract][Full Text] [Related]
2. Regenerative medicine of the kidney. Perin L; Da Sacco S; De Filippo RE Adv Drug Deliv Rev; 2011 Apr; 63(4-5):379-87. PubMed ID: 21145933 [TBL] [Abstract][Full Text] [Related]
3. Stem cell and regenerative science applications in the development of bioengineering of renal tissue. Perin L; Giuliani S; Sedrakyan S; DA Sacco S; De Filippo RE Pediatr Res; 2008 May; 63(5):467-71. PubMed ID: 18427289 [TBL] [Abstract][Full Text] [Related]
4. Repairing the chronic damaged kidney: the role of regenerative medicine. Caldas HC; Hayashi AP; Abbud-Filho M Transplant Proc; 2011 Dec; 43(10):3573-6. PubMed ID: 22172807 [TBL] [Abstract][Full Text] [Related]
5. Lessons from (patho)physiological tissue stiffness and their implications for drug screening, drug delivery and regenerative medicine. Chen WL; Simmons CA Adv Drug Deliv Rev; 2011 Apr; 63(4-5):269-76. PubMed ID: 21241759 [TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
17. In vitro regeneration of kidney from pluripotent stem cells. Osafune K Exp Cell Res; 2010 Oct; 316(16):2571-7. PubMed ID: 20451514 [TBL] [Abstract][Full Text] [Related]
18. Cell and drug delivery therapeutics for controlled renal parenchyma regeneration. Minuth WW; Denk L; Glashauser A Adv Drug Deliv Rev; 2010 Jun; 62(7-8):841-54. PubMed ID: 20122975 [TBL] [Abstract][Full Text] [Related]